MediVentures
Investment Details
Investor Type
Family Office
Asset Class Focus
Venture Capital, Private Equity
Stage Focus
Pre-Seed, Seed, Series A, Series B, Early Stage
Geographical Focus
United States, United Kingdom, Germany, Israel, European Union
Industries Focus
- Healthcare
- Renewable Energy
- HealthTech
- Life Sciences
- Digital Health
- Pharmaceuticals
- Diagnostics
- Sustainability
- Medtech
- Agricultural Technology
- Biotechnology
- Healthcare Technology
- Clean Energy
- Environmental Technology
- Space Technology
- Climate Technology
- Nutrition
- Ag-tech
Investment Size:
5,000,000 to 5,000,000 USD
Investor Details Founded: 2019
MediVentures is the venture capital arm of the Puetter family office, established in 2019. It focuses on early-stage investments in digital health ventures, aiming to promote future-proof technologies within a sustainable healthcare system. In 2024, MediVentures shifted its strategy to invest in venture capital funds, allowing for opportunistic co-investments with partner funds. This approach enables them to support a broader range of innovative healthcare solutions.
The firm's investment interests encompass digital health, nutrition, clean and reliable energy, environmental and climate technology, agricultural technology, and space technology. They seek to collaborate with established and first-time general partners, committing up to €5 million per fund. MediVentures emphasizes flexibility and speed in decision-making, leveraging its private ownership to act decisively.
MediVentures' portfolio includes direct investments in companies like Actitrexx GmbH, which focuses on preventing Graft-versus-Host-Disease through cellular therapy, and Brainjo GmbH, offering virtual reality solutions for burnout prevention and movement compensation in corporate health management. Additionally, they have invested in Keleya Digital-Health Solutions GmbH, supporting expectant mothers and young families with digital access to valuable information and services during pregnancy and early parenthood.
Requirements
- Established and first-time General Partners (GPs) seeking limited partner positions in their funds
- Funds with the capacity for opportunistic co-investments
- Funds primarily active in the European Union, EFTA, and the United Kingdom, with select positions in the United States and Israel
- Funds focusing on digital health, nutrition, clean and reliable energy, environmental and climate technology, ag-tech, and space
- Funds investing in pre-seed, Series A, and Series B stages
- Special funds for secondary investments and profit-driven impact funds may also be of interest
Contact
[Official Website Hidden]
[LinkedIn Profile Hidden]
[HQ Location Hidden]
[Email Hidden]
Portfolio Companies
- Actitrexx GmbH
- Anvajo GmbH
- XO Life GmbH
- Brainjo GmbH
- Keleya Digital-Health Solutions GmbH
Mentioned In
-
$24.95
-
$24.95
-
$19.95
-
$19.95
-
$19.95
-
$49.95
-
$39.95
-
$99.00
-
$245.00
Claim this Investor
Are you an official representative of MediVentures?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim